# FDA Inspection 1121213 - OneBlood, Inc. - January 23, 2020

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/46fc35c2-598f-465b-9459-78a275c2d775
Source feed: FDA_Inspections

> FDA Inspection 1121213 for OneBlood, Inc. on January 23, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121213
- Company Name: OneBlood, Inc.
- Inspection Date: 2020-01-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1255914 - 2024-12-03](https://www.keypedia.com/records/fda_inspections/oneblood-inc/6b44a21b-7f46-4f11-958d-ebaf57c3c021)
- [FDA Inspection 1255914 - 2024-12-03](https://www.keypedia.com/records/fda_inspections/oneblood-inc/b0cfe414-bd12-44a4-a312-6587eab16efa)
- [FDA Inspection 1054440 - 2018-04-09](https://www.keypedia.com/records/fda_inspections/oneblood-inc/af331f3b-011c-443f-9591-2cb5f745b42c)
- [FDA Inspection 987803 - 2016-06-29](https://www.keypedia.com/records/fda_inspections/oneblood-inc/d45e547d-5912-4f6d-afd4-c422d1d3bf7d)
- [FDA Inspection 892674 - 2014-08-26](https://www.keypedia.com/records/fda_inspections/oneblood-inc/4cf98de8-ac53-49c8-a7f8-de855aae711c)

Company: https://www.keypedia.com/companies/oneblood-inc/032e61cd-4eae-49af-9cc9-22061de23307

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d